Disseminated fungal infection in a patient receiving zanubrutinib.
- Resource Type
- Case Study
- Authors
- Walsh, Madalyn; Xu, Alice; Ballas, Zuhair; Sanchez, Rolando
- Source
- Clinical Case Reports. Jun2023, Vol. 11 Issue 6, p1-4. 4p.
- Subject
- *BRUTON tyrosine kinase
*MYCOSES
*PROTEIN-tyrosine kinase inhibitors
- Language
- ISSN
- 2050-0904
Key Clinical Message: We report a case of fatal disseminated aspergillosis in the setting of administration of zanubrutinib, a second‐generation Bruton's tyrosine kinase inhibitor thought to have a lower rate of immunosuppression‐related side effects. [ABSTRACT FROM AUTHOR]